IBDEI0HG ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8133,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,8133,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,8133,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,8134,0)
 ;;=626.1^^35^481^35
 ;;^UTILITY(U,$J,358.3,8134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8134,1,4,0)
 ;;=4^626.1
 ;;^UTILITY(U,$J,358.3,8134,1,5,0)
 ;;=5^Oligomenorrhea
 ;;^UTILITY(U,$J,358.3,8134,2)
 ;;=Oligomenorrhea^108125
 ;;^UTILITY(U,$J,358.3,8135,0)
 ;;=733.00^^35^481^36
 ;;^UTILITY(U,$J,358.3,8135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8135,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,8135,1,5,0)
 ;;=5^Osteoporosis
 ;;^UTILITY(U,$J,358.3,8135,2)
 ;;=Osteoporosis^87159
 ;;^UTILITY(U,$J,358.3,8136,0)
 ;;=626.5^^35^481^38
 ;;^UTILITY(U,$J,358.3,8136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8136,1,4,0)
 ;;=4^626.5
 ;;^UTILITY(U,$J,358.3,8136,1,5,0)
 ;;=5^Ovulation Bleeding
 ;;^UTILITY(U,$J,358.3,8136,2)
 ;;=Ovulation Bleeding^270570
 ;;^UTILITY(U,$J,358.3,8137,0)
 ;;=625.2^^35^481^39
 ;;^UTILITY(U,$J,358.3,8137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8137,1,4,0)
 ;;=4^625.2
 ;;^UTILITY(U,$J,358.3,8137,1,5,0)
 ;;=5^Ovulation Pain
 ;;^UTILITY(U,$J,358.3,8137,2)
 ;;=Ovulation Pain^265259
 ;;^UTILITY(U,$J,358.3,8138,0)
 ;;=614.9^^35^481^42
 ;;^UTILITY(U,$J,358.3,8138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8138,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,8138,1,5,0)
 ;;=5^Pelvic inflammatory disease
 ;;^UTILITY(U,$J,358.3,8138,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,8139,0)
 ;;=789.30^^35^481^40
 ;;^UTILITY(U,$J,358.3,8139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8139,1,4,0)
 ;;=4^789.30
 ;;^UTILITY(U,$J,358.3,8139,1,5,0)
 ;;=5^Pelvic Mass
 ;;^UTILITY(U,$J,358.3,8139,2)
 ;;=Pelvic Mass^917
 ;;^UTILITY(U,$J,358.3,8140,0)
 ;;=622.7^^35^481^44
 ;;^UTILITY(U,$J,358.3,8140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8140,1,4,0)
 ;;=4^622.7
 ;;^UTILITY(U,$J,358.3,8140,1,5,0)
 ;;=5^Polyp of Cervix
 ;;^UTILITY(U,$J,358.3,8140,2)
 ;;=Polyp of Cervix^79612
 ;;^UTILITY(U,$J,358.3,8141,0)
 ;;=627.1^^35^481^45
 ;;^UTILITY(U,$J,358.3,8141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8141,1,4,0)
 ;;=4^627.1
 ;;^UTILITY(U,$J,358.3,8141,1,5,0)
 ;;=5^Postmenopausal bleeding
 ;;^UTILITY(U,$J,358.3,8141,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,8142,0)
 ;;=V24.2^^35^481^46
 ;;^UTILITY(U,$J,358.3,8142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8142,1,4,0)
 ;;=4^V24.2
 ;;^UTILITY(U,$J,358.3,8142,1,5,0)
 ;;=5^Postpartum
 ;;^UTILITY(U,$J,358.3,8142,2)
 ;;=Postpartum^114052
 ;;^UTILITY(U,$J,358.3,8143,0)
 ;;=V22.2^^35^481^47
 ;;^UTILITY(U,$J,358.3,8143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8143,1,4,0)
 ;;=4^V22.2
 ;;^UTILITY(U,$J,358.3,8143,1,5,0)
 ;;=5^Pregnancy Status
 ;;^UTILITY(U,$J,358.3,8143,2)
 ;;=Pregnancy Status^97923
 ;;^UTILITY(U,$J,358.3,8144,0)
 ;;=627.0^^35^481^48
 ;;^UTILITY(U,$J,358.3,8144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8144,1,4,0)
 ;;=4^627.0
 ;;^UTILITY(U,$J,358.3,8144,1,5,0)
 ;;=5^Premenopausal menorrhagia
 ;;^UTILITY(U,$J,358.3,8144,2)
 ;;=^270575
 ;;^UTILITY(U,$J,358.3,8145,0)
 ;;=625.4^^35^481^49
 ;;^UTILITY(U,$J,358.3,8145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8145,1,4,0)
 ;;=4^625.4
 ;;^UTILITY(U,$J,358.3,8145,1,5,0)
 ;;=5^Premenstrual tension
 ;;^UTILITY(U,$J,358.3,8145,2)
 ;;=^98014
 ;;^UTILITY(U,$J,358.3,8146,0)
 ;;=302.70^^35^481^51
 ;;^UTILITY(U,$J,358.3,8146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8146,1,4,0)
 ;;=4^302.70
 ;;^UTILITY(U,$J,358.3,8146,1,5,0)
 ;;=5^Sexual dysfunction, psychosexual
 ;;^UTILITY(U,$J,358.3,8146,2)
 ;;=^100647
 ;;
 ;;$END ROU IBDEI0HG
